RAC 2.92% $1.94 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-37

  1. 140 Posts.
    lightbulb Created with Sketch. 19
    Doesn't seem like anyone cares based on the share price and volume
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.